Your session is about to expire
← Back to Search
Behavioral Intervention
Remote Mindfulness Education for Vulvodynia
N/A
Waitlist Available
Led By Catherine Leclair, MD
Research Sponsored by Oregon Health and Science University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Reported dyspareunia for at least 3 months in non-pregnant, healthy women over aged 18 years old and estrogen replete with confirmed diagnosis of provoked localized vulvodynia (PVL) or positive Q-tip test, meeting Friedrich's criteria for PLV.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline & 8 weeks
Awards & highlights
Study Summary
This trial is testing an online education and mindfulness program to see if it can help with vulvodynia pain and anxiety.
Who is the study for?
This trial is for non-pregnant, healthy women over 18 with confirmed provoked localized vulvodynia (PLV) who have experienced pain during intercourse for at least 3 months. Participants need phone and internet access, the ability to use a tampon, and must not be currently receiving sexual counseling or mindfulness training.Check my eligibility
What is being tested?
The study is testing an online program that combines education with mindfulness exercises to help manage pain and anxiety associated with PLV. The effectiveness of this remote intervention will be evaluated through participants' experiences.See study design
What are the potential side effects?
Since the interventions involve non-invasive practices like education and mindfulness training, significant side effects are not expected. However, some individuals might experience discomfort or emotional distress when confronting their condition.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am a woman over 18, not pregnant, with painful intercourse for 3+ months, diagnosed with PVL.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline & 8 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline & 8 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Female Sexual Distress Scale (FSDS) at 8 weeks
Secondary outcome measures
Change in Tampon Test Pain Scores at 8 weeks
Trial Design
2Treatment groups
Active Control
Group I: Mindfulness & EducationActive Control1 Intervention
Mindfulness practice using guided HeadSpace medications plus educational materials
Group II: Education onlyActive Control1 Intervention
Educational materials only
Find a Location
Who is running the clinical trial?
Oregon Health and Science UniversityLead Sponsor
973 Previous Clinical Trials
6,845,983 Total Patients Enrolled
Catherine Leclair, MDPrincipal InvestigatorOregon Health and Science University
3 Previous Clinical Trials
199 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I speak English fluently.You have a cell phone that can download apps.You should be able to use a Tampax® tampon without any difficulty.I experience pain during intercourse due to conditions like endometriosis or skin issues.I regularly practice meditation.I am a woman over 18, not pregnant, with painful intercourse for 3+ months, diagnosed with PVL.I am a woman over 18, not pregnant, with painful intercourse for 3+ months and diagnosed with PVL.I have participated in sexual counseling or mindfulness training in the last 6 months.
Research Study Groups:
This trial has the following groups:- Group 1: Mindfulness & Education
- Group 2: Education only
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Do I meet the criteria to take part in this medical experiment?
"This clinical study is looking to accomodate 46 patients suffering from provoked, localized vulvodynia and aged between 18-100 years old."
Answered by AI
Is geriatric recruitment being facilitated for this experiment?
"The age range for potential study participants is between 18 years old and a century."
Answered by AI
Are there any enrolment opportunities for this experiment yet?
"According to clinicaltrials.gov, this medical study is not currently accepting test subjects. The trial was first posted on May 1st 2018 with its last update being made September 21st 2022. Even though no participants are accepted presently, there are 11 other active trials looking for volunteers."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger